FDA cracking down on use of petitions to delay generics

Submitted by admin on October 2, 2018 - 7:49pm

Source:

BioCentury

News Tags:

FDA

citizen petitions

generics

anticompetitive practices

Headline:

FDA cracking down on use of petitions to delay generics

snippet:

FDA released draft guidance Tuesday aimed at reducing the use of 505(q) Citizen's Petitions intended to delay market entry of generic drugs. In a statement, FDA Commissioner Scott Gottlieb said some parties have used the petitions among "anticompetitive techniques."

Search form

You are here

FDA cracking down on use of petitions to delay generics

FDA cracking down on use of petitions to delay generics